Hospital Universitario HM Sanchinarro-START MADRID-CIOCC

Madrid 28050

2 studies enrolling now · 3 studies all time

What they study most

Advanced Solid Cancers, Cholangiocarcinoma, FGFR2 Amplification, FGFR2 Gene Activation, FGFR2 Gene Fusion/Rearrangement, FGFR2 Gene Mutation, FGFR2 Gene Translocation, Intrahepatic Cholangiocarcinoma, Other Solid Tumors, Adult

Studies at this site

• A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement — Recruiting now
• A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9 — Recruiting now
• REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors — Completed